Pharmaceutical Sector of Nifty Index Records a 0.56% Growth in Stock Market

Pharmaceutical Sector of Nifty Index Records a 0.56% Growth in Stock Market


The Nifty Pharma Index Closes Higher

The Nifty Pharma index closed on a positive note, with several pharmaceutical companies seeing gains. Granules India Ltd., Ipca Laboratories Ltd., Biocon Ltd., Laurus Labs Ltd., and Sun Pharmaceutical Industries Ltd. were the top gainers of the day. However, Divi’s Laboratories Ltd., Abbott India Ltd., GlaxoSmithKline Pharmaceuticals Ltd., Pfizer Ltd., and Glenmark Pharmaceuticals Ltd. ended as the top losers.

The Nifty Pharma index closed at 15990.1, marking a 0.56% increase. The benchmark NSE Nifty50 index ended up 206.9 points at 20096.6, while the BSE Sensex stood up 727.71 points at 66901.91.

Market Performance

Out of the 50 stocks in the Nifty index, 40 closed in the green, while 9 closed in the red. Some of the most traded shares on the NSE were Indian Renewable, JP Power, Vodafone Idea, Reliance Power, and Suzlon Energy.

Aster DM Health, Shradha Infraproject, Marksans Pharma, Torrent Power, and Minda Corp. reached their fresh 52-week highs during today’s trade. On the other hand, Bohra Industries, Karda Const, Fourth Dimension Sol, Raj Rayon, and SEL Manufact hit their fresh 52-week lows.

Hot Take: Pharma Sector Shows Positive Momentum

Read Disclaimer
This page is simply meant to provide information. It does not constitute a direct offer to purchase or sell, a solicitation of an offer to buy or sell, or a suggestion or endorsement of any goods, services, or businesses. Lolacoin.org does not offer accounting, tax, or legal advice. When using or relying on any of the products, services, or content described in this article, neither the firm nor the author is liable, directly or indirectly, for any harm or loss that may result. Read more at Important Disclaimers and at Risk Disclaimers.

The pharmaceutical sector has shown positive momentum with the Nifty Pharma index closing higher. This indicates a favorable market sentiment towards pharmaceutical companies. It is important to keep an eye on individual stock performances within the sector to identify potential investment opportunities or risks.

Author – Contributor at | Website

Cindy Dutta emerges as a polymath of the crypto realm, seamlessly blending the roles of analyst, researcher, and editorial virtuoso. Navigating the intricate labyrinth of cryptocurrencies, Cindy unfurls intricate patterns of digital assets, resonating harmoniously with minds of all kinds. Her knack for unraveling enigmatic crypto intricacies intertwines effortlessly with her editorial finesse, transmuting complexity into an immersive symphony of comprehension.